Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-028714

SVP, Head of Global Commercial sold 1,544 shares at $40.15 ($61,992)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2018-05-08 Sale −1,544 $40.15 $61,992 12,500 D: show line 1 in the form
Open-market sales · 1,544 sh · avg $40.15 · $61,992
Loading xslF345X03/doc4.xml…